Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis.

  • Read more about Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis.

Immunoreactive inhibin, müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors.

  • Read more about Immunoreactive inhibin, müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors.

Clinical characteristics of antiphospholipid antibody syndrome in children.

  • Read more about Clinical characteristics of antiphospholipid antibody syndrome in children.

Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.

  • Read more about Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.

Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation.

  • Read more about Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation.

Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.

  • Read more about Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.

Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1.

  • Read more about Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1.

Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin.

  • Read more about Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin.

Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.

  • Read more about Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.

Effects of a long-term transfusion regimen on sickle cell-related illnesses.

  • Read more about Effects of a long-term transfusion regimen on sickle cell-related illnesses.

Pagination

  • Previous page ‹‹
  • Page 29
  • Next page ››
Subscribe to The Journal of pediatrics

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List